Biocon’s S&P Global ESG Score improves to 69 for 2024
Biocon’s subsidiary Biocon Biologics Limited, which also participated independently in the assessment for the first time, reported an S&P Global ESG Score of 53
Biocon’s subsidiary Biocon Biologics Limited, which also participated independently in the assessment for the first time, reported an S&P Global ESG Score of 53
Exploring new opportunities within the fast-growing market of microfluidics
The report highlights Piramal Pharma’s approach across four key strategic pillars: Responsible Operations, Business Resilience, Customer Centricity, and Quality & Excellence
Aragen Life Sciences is the first Indian CRDMO to receive SBTi approval
Target identification will commence on 17 September 2024, following the timeline provided in the campaign guidelines
Critical resources will help Genvor to grow and scale biological crop protection products and innovative trait technologies
Becomes the first rehab & recovery center in east India to earn NABH accreditation
Aims to become a leading global partner for botanical extracts and natural actives in the beauty and personal care market
Dr Sheth's will commission a Healthmobile on Wheels initiative to ensure that healthcare doesn't remain confined to urban centers
Subscribe To Our Newsletter & Stay Updated